| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | 详情 |
| L864493 | MACKLIN | Loperamide HCl | 98% | 96元/1g; 391元/5g; 1567元/25g; 3888元/100g; | 展开 |
|
| L792694 | MACKLIN | Loperamide HCl | 10mM in DMSO | 417元/1ml; | 展开 |
|
| L0154 | TCI | Loperamide Hydrochloride | >98.0%(T)(HPLC) | 490元/5G; 1990元/25G; | 展开 |
基本信息 | 纯度/分析方法 | >98.0%(T)(HPLC) | | 分子式/分子量 | C29H33ClN2O2・HCl = 513.50 | | 外观与形状(20℃) | 固体 | | 相关CAS RN | 53179-11-6 | | Reaxys-RN | 4087090 | | PubChem物质ID | 87572105 | | Merck Index (14) | 5571 | | MDL编号 | MFCD00058581 |
技术规格 | Appearance | White to Almost white powder to crystal | | Purity(HPLC) | min. 98.0 area% | | Purity(Nonaqueous Titration) | min. 98.0 % | | Solubility in Methanol | almost transparency |
物性(参考值) | 熔点 | 223 ℃ | | 水溶性 | 不溶 | | 溶解性(可溶于) | 二氯甲烷,乙醇 | | 溶解性(不溶于) | 乙醚 |
安全信息 | 图形或危害标志 |  | | 信号词 | 危险 | | 危险性说明 | H301 : 吞咽会中毒。
| | 防范说明 | P501 : 将内装物/容器送到批准的废物处理厂处理。 P270 : 使用本产品时不要进食、饮水或吸烟。 P264 : 作业后彻底清洗皮肤。 P301 + P310 + P330 : 如误吞咽:立即呼叫急救中心/医生。漱口。 P405 : 存放处须加锁。
|
相关法规 运输信息 | UN编号 | UN2811 | | 类别 | 6.1 | | 包装类别 | III | | 监管条件代码(*) | |
|
| 988688 | J&K | Loperamide Hydrochloride | 98%, 阿片类受体激动剂 | 941元/5G; 2556元/25G; | 展开 |
基本信息 | 分子式 | C29H33ClN2O2·HCl | | 分子量 | 513.50 | | 熔点 | 223 | | 沸点 | 223 | | MDL编码 | MFCD00058581 | | Beilstein | 4087090 | | Merck | 14,5571 | | EINECS 编号 | 252-082-4 | 产品描述 Loperamide HCl是一种阿片受体激动剂,ED50为0.15 mg/kg。 靶点(IC50 & Targe) δ-opioid receptor,48nM(Ki) κ-opioid receptor,48nM(Ki) μ-opioid receptor,3.3nM(Ki) 体外研究 与人的阿片受体 delta (Ki = 48 nM)和kappa (Ki = 1156 nM)相比,Loperamide表现对micro受体的高亲和力。在转染了阿片受体的人中国仓鼠卵巢细胞,Loperamide强效刺激结合[35S]鸟苷5'-O-(3-硫代)三磷酸,EC50为56 nM,并抑制forskolin刺激的cAMP累积(IC 50 =25 nM)。Loperamide在intrapaw注射后有效抑制晚期阶段福尔马林诱导退缩。[1] Loperamide是CES2的强抑制剂,Ki为1.5 muM,但它只能微弱抑制CES1A1(IC 50 =0.44 mM)。[2] 与人的阿片受体 delta (Ki = 48 nM)和kappa (Ki = 1156 nM)相比,Loperamide以浓度依赖的方式可逆阻断K+o诱发的Ca2+ i的上升,IC50为0.9 mM。Loperamide(0.1-50 mM)浓度依赖性降低IBA峰值,IC50为2.5 mM。在试验的最高浓度,Loperamide在没有任何其它药理学试剂时充分阻止IBa。在膜电位为-60毫伏时,Loperamide也衰减NMDA诱发的电流,IC50为73 mM。[3] 体内研究 在小鼠局部胫骨肿瘤(7.5-75毫克)或颈部(4毫克/千克)的毛皮下,Loperamide,阿片样激动剂无法穿越血-脑屏障,皮下注射时同时抑制热和机械痛觉过敏。[4] 参考文献 [1] DeHaven-Hudkins DL, et al. J Pharmacol Exp Ther,?999, 289(1), 494-502. [2] Quinney SK, et al. J Pharmacol Exp Ther,?005, 313(3), 1011-1016. [3] Church J, et al. Mol Pharmacol,?994, 45(4), 747-757. [4] Menéndez L, et al. Pharmacol Biochem Behav,?005, 81(1), 安全信息 | 图形或危害标志 |  | | 提示语 | Danger | | 危险说明 | H301 | | 防范说明 | P301+P310 | | UN号码 | 2811 | | 危险分类 | 6.1 | | 包装等级 | III | | WGK | 3 | | RTECS | TM4960000 | | TSCA | 否 |
|
| PHR1162 | Supelco | Loperamide Hydrochloride | Pharmaceutical Secondary Standard; Certified Reference Material | 941.08元/1 G; | 展开 |
产品说明 一般描述 Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards. Loperamide hydrochloride finds application in the regulation and symptomatic relief of long acting diarrhea linked with inflammatory bowel diseases. It can also be used as a muscle relaxant agent. 应用 Loperamide hydrochloride may be used as a pharmaceutical reference standard for the determination of the analyte in pharmaceutical formulations by spectrophotometric and chromatography techniques. These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements. 分析说明 These secondary standards offer multi-traceability to the USP, EP (PhEur) and BP primary standards, where they are available. 其他说明 Values of analytes vary lot to lot. This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis. 附注 To see an example of a Certificate of Analysis for this material enter LRAC3771 in the slot below. This is an example certificate only and may not be the lot that you receive. 基本信息 | 经验(实验)分子式 | C29H33ClN2O2 · HCl | | 分子量 | 513.50 | | EC 号 | 252-082-4 | | MDL编号 | MFCD00058581 | | PubChem化学物质编号 | 329823179 | | NACRES | NA.24 |
产品性质 | 质量水平 | 300 | | 等级 | certified reference material pharmaceutical secondary standard | | CofA | current certificate can be downloaded | | technique(s) | HPLC: suitable gas chromatography (GC): suitable | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | 药典可追溯性 | traceable to BP 635 traceable to PhEur L0750000 traceable to USP 1370000 | | 储存温度 | 2-30℃ | | SMILES string | Cl.CN(C)C(=O)C(CCN1CCC(O)(CC1)c2ccc(Cl)cc2)(c3ccccc3)c4ccccc4 | | InChI | 1S/C29H33ClN2O2.ClH/c1-31(2)27(33)29(24-9-5-3-6-10-24,25-11-7-4-8-12-25)19-22-32-20-17-28(34,18-21-32)23-13-15-26(30)16-14-23;/h3-16,34H,17-22H2,1-2H3;1H | | InChI key | PGYPOBZJRVSMDS-UHFFFAOYSA-N | | Gene Information | human ... OPRM1(4988) |
安全信息 | 象形图 |  | | 警示用语: | Danger | | 危险声明 | H301 | | 预防措施声明 | P301 + P310 | | 危险分类 | Acute Tox. 3 Oral | | 储存分类代码 | 6.1D - Non-combustible, acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| L0750000 | | Loperamide Hydrochloride | European Pharmacopoeia (EP) Reference Standard | 1277.32元/ ; | 展开 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 包装 Unit quantity: 50 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 注意 Please find SDS provided by EDQM here.. 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C29H33ClN2O2 · HCl | | 分子量 | 513.50 | | MDL编号 | MFCD00058581 | | PubChem化学物质编号 | 329817374 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | agency | EP Reference Standard | | manufacturer/tradename | EDQM | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | SMILES string | Cl.CN(C)C(=O)C(CCN1CCC(O)(CC1)c2ccc(Cl)cc2)(c3ccccc3)c4ccccc4 | | InChI | 1S/C29H33ClN2O2.ClH/c1-31(2)27(33)29(24-9-5-3-6-10-24,25-11-7-4-8-12-25)19-22-32-20-17-28(34,18-21-32)23-13-15-26(30)16-14-23;/h3-16,34H,17-22H2,1-2H3;1H | | InChI key | PGYPOBZJRVSMDS-UHFFFAOYSA-N | | Gene Information | human ... OPRM1(4988) |
安全信息 | 象形图 |  | | 警示用语: | Danger | | 危险声明 | H301 | | 预防措施声明 | P301 + P310 + P330 | | 危险分类 | Acute Tox. 3 Oral | | 储存分类代码 | 6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects | | WGK | WGK 3 |
|
| L4762 | Sigma-Aldrich | Loperamide Hydrochloride | | 1812.02元/5 G; 5759.61元/25 G; | 展开 |
产品说明 应用 盐酸洛哌丁胺 (HCl) 已用于炎性疼痛实验和评估蛋白质的功能性。54 生化/生理作用 盐酸洛哌丁胺 (HCl) 是一种非选择性 Ca 2 + 通道阻滞剂。在纳摩尔浓度下,与 μ-阿片受体。盐酸洛哌丁胺不能通过血脑屏障。 特点和优势 这种化合物是ADME毒性研究的特色产品。点击此处发现更多特色ADME毒性产品。在sigma.com/discover-bsm可了解更多关于生物活性小分子的其他研究领域。 该化合物由 Johnson & Johnson 开发。如需浏览其他制药公司开发的化合物和批准的药物/候选药物列表,请点击此处。 制备说明 微溶于水和稀酸,易溶于甲醇和氯仿,可溶于95%乙醇。 基本信息 | 经验(实验)分子式 | C29H33ClN2O2 · HCl | | 分子量 | 513.50 | | EC 号 | 252-082-4 | | MDL编号 | MFCD00058581 | | PubChem化学物质编号 | 24278042 | | NACRES | NA.77 |
产品性质 | 质量水平 | 200 | | 创始人 | Johnson & Johnson | | SMILES string | Cl.CN(C)C(=O)C(CCN1CCC(O)(CC1)c2ccc(Cl)cc2)(c3ccccc3)c4ccccc4 | | InChI | 1S/C29H33ClN2O2.ClH/c1-31(2)27(33)29(24-9-5-3-6-10-24,25-11-7-4-8-12-25)19-22-32-20-17-28(34,18-21-32)23-13-15-26(30)16-14-23;/h3-16,34H,17-22H2,1-2H3;1H | | InChI key | PGYPOBZJRVSMDS-UHFFFAOYSA-N | | Gene Information | human ... OPRM1(4988) |
安全信息 | 象形图 |  | | 警示用语: | Danger | | 危险声明 | H301 | | 预防措施声明 | P264 - P270 - P301 + P310 + P330 - P405 - P501 | | 危险分类 | Acute Tox. 3 Oral | | 储存分类代码 | 6.1D - Non-combustible, acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects | | WGK | WGK 3 | | 个人防护装备 | Eyeshields, Faceshields, Gloves, type P2 (EN 143) respirator cartridges |
|
| 34014 | Supelco | Loperamide Hydrochloride | VETRANAL®, analytical standard | 513.95元/100 MG; | 展开 |
产品说明 一般描述 洛哌丁胺是一种止泻药,用于控制急性非特异性腹泻和炎症性肠病相关的慢性腹泻症状。 应用 盐酸洛哌丁胺可作为分析参考标准品,用于通过不同色谱技术对生物体液中的分析物进行定量分析。 有关合适仪器技术的更多信息,请参考产品′s分析证书。如需进一步支持,请联系技术服务。 法律信息 VETRANAL is a registered trademark of sigma-aldrich Chemie GmbH 基本信息 | 经验(实验)分子式 | C29H33ClN2O2 · HCl | | 分子量 | 513.50 | | EC 号 | 252-082-4 | | MDL编号 | MFCD00058581 | | PubChem化学物质编号 | 329754758 | | NACRES | NA.24 |
产品性质 | 等级 | analytical standard | | 质量水平 | 100 | | 产品线 | VETRANAL® | | 保质期 | limited shelf life, expiry date on the label | | technique(s) | HPLC: suitable gas chromatography (GC): suitable | | application(s) | forensics and toxicology pharmaceutical (small molecule) | | 格式 | neat | | SMILES string | Cl.CN(C)C(=O)C(CCN1CCC(O)(CC1)c2ccc(Cl)cc2)(c3ccccc3)c4ccccc4 | | InChI | 1S/C29H33ClN2O2.ClH/c1-31(2)27(33)29(24-9-5-3-6-10-24,25-11-7-4-8-12-25)19-22-32-20-17-28(34,18-21-32)23-13-15-26(30)16-14-23;/h3-16,34H,17-22H2,1-2H3;1H | | InChI key | PGYPOBZJRVSMDS-UHFFFAOYSA-N | | Gene Information | human ... OPRM1(4988) |
安全信息 | 象形图 |  | | 警示用语: | Danger | | 危险声明 | H301 | | 预防措施声明 | P301 + P310 | | 危险分类 | Acute Tox. 3 Oral | | 储存分类代码 | 6.1D - Non-combustible, acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable | | 个人防护装备 | Eyeshields, Faceshields, Gloves, type P2 (EN 143) respirator cartridges |
|
| Y0002087 | | Loperamide for system suitability | European Pharmacopoeia (EP) Reference Standard | 1569.39元/ ; | 展开 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 包装 Unit quantity: 15 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C29H33ClN2O2 · HCl | | 分子量 | 513.50 | | MDL编号 | MFCD00058581 |
产品性质 | manufacturer/tradename | EDQM | | 储存温度 | 2-8℃ | | SMILES string | Cl.CN(C)C(=O)C(CCN1CCC(O)(CC1)c2ccc(Cl)cc2)(c3ccccc3)c4ccccc4 | | InChI | 1S/C29H33ClN2O2.ClH/c1-31(2)27(33)29(24-9-5-3-6-10-24,25-11-7-4-8-12-25)19-22-32-20-17-28(34,18-21-32)23-13-15-26(30)16-14-23;/h3-16,34H,17-22H2,1-2H3;1H | | InChI key | PGYPOBZJRVSMDS-UHFFFAOYSA-N | | Gene Information | human ... OPRM1(4988) |
安全信息 | 象形图 |  | | 警示用语: | Danger | | 危险声明 | H301 | | 预防措施声明 | P264 - P270 - P301 + P310 - P405 - P501 | | 危险分类 | Acute Tox. 3 Oral | | 储存分类代码 | 6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects | | WGK | WGK 3 |
|
| BP635 | | Loperamide Hydrochloride | British Pharmacopoeia (BP) Reference Standard | 2189.77元/100 MG; | 展开 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 包装 Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C29H33ClN2O2 · HCl | | 分子量 | 513.50 | | MDL编号 | MFCD00058581 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | BP | | 格式 | neat | | 储存温度 | 2-8℃ | | SMILES string | Cl.CN(C)C(=O)C(CCN1CCC(O)(CC1)c2ccc(Cl)cc2)(c3ccccc3)c4ccccc4 | | InChI | 1S/C29H33ClN2O2.ClH/c1-31(2)27(33)29(24-9-5-3-6-10-24,25-11-7-4-8-12-25)19-22-32-20-17-28(34,18-21-32)23-13-15-26(30)16-14-23;/h3-16,34H,17-22H2,1-2H3;1H | | InChI key | PGYPOBZJRVSMDS-UHFFFAOYSA-N | | Gene Information | human ... OPRM1(4988) |
安全信息 | 象形图 |  | | 警示用语: | Danger | | 危险声明 | H301 | | 预防措施声明 | P301 + P330 + P331 + P310 | | 危险分类 | Acute Tox. 3 Oral | | 储存分类代码 | 6.1D - Non-combustible, acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| 1370000 | USP | Loperamide Hydrochloride | United States Pharmacopeia (USP) Reference Standard | 3231.47元/200 MG; | 展开 |
产品说明 分析说明 These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. 其他说明 USP issued SDS can be found here. Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C29H33ClN2O2 · HCl | | 分子量 | 513.50 | | MDL编号 | MFCD00058581 | | PubChem化学物质编号 | 329750255 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | USP | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | SMILES string | Cl.CN(C)C(=O)C(CCN1CCC(O)(CC1)c2ccc(Cl)cc2)(c3ccccc3)c4ccccc4 | | InChI | 1S/C29H33ClN2O2.ClH/c1-31(2)27(33)29(24-9-5-3-6-10-24,25-11-7-4-8-12-25)19-22-32-20-17-28(34,18-21-32)23-13-15-26(30)16-14-23;/h3-16,34H,17-22H2,1-2H3;1H | | InChI key | PGYPOBZJRVSMDS-UHFFFAOYSA-N | | Gene Information | human ... OPRM1(4988) |
安全信息 | 象形图 |  | | 警示用语: | Danger | | 危险声明 | H301 | | 预防措施声明 | P301 + P330 + P331 + P310 | | 危险分类 | Acute Tox. 3 Oral | | 储存分类代码 | 6.1D - Non-combustible, acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| 358128 | Fluorochem | 4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-N,N-dimethyl-2,2-diphenylbutanamide hydrochloride | 98.0% | 286元/1g; 880元/5g; 2970元/25g; | 展开 |
基本信息 | CAS Number | 34552-83-5 | | MDL Number | MFCD00058581 |
安全信息 | 图形或危害标志 |   | | 危险性说明 | H301: Toxic if swallowed. H315: Causes skin irritation. H319: Causes serious eye irritation. H335: May cause respiratory irritation.
| | 防范说明 | P233: Keep container tightly closed. P260: Do not breathe . P261: Avoid breathing P264: Wash hands thoroughly after handling. P270: Do not eat, drink or smoke when using this product. P271: Use only outdoors or in a well-ventilated area. P280: Wear . P301 + P310: IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. P302 + P352: IF ON SKIN: Wash with plenty of soap and water. P304: IF INHALED: . P304 + P340: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing. P305 + P351 + P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P312: Call a POISON CENTER or doctor/physician if you feel unwell. P321: Specific treatment (see . on this label). P330: Rinse mouth. P332 + P313: If skin irritation occurs: Get medical advice/ attention. P337 + P313: If eye irritation persists: Get medical advice/attention. P340: Remove victim to fresh air and keep at rest in a position comfortable for breathing. P362: Take off contaminated clothing and wash before reuse. P403: Store in a well-ventilated place. P403 + P233: Store in a well-ventilated place. Keep container tightly closed. P405: Store locked up. P501: Dispose of contents/container to local regulations.
|
|